title: An open-label study of aripiprazole in nonschizophrenic crack-dependent patients.
authors.forename: Florence
authors.initials: F
authors.lastname: Vorspan
authors.forename: Laetitia
authors.initials: L
authors.lastname: Bellais
authors.forename: Lenneke
authors.initials: L
authors.lastname: Keijzer
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Lépine
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D019970:Cocaine-Related Disorders / Q000188:drug therapy* / Q000534:rehabilitation; D016578:Crack Cocaine / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016320:Substance Abuse Treatment Centers
chemical_list: D014150:Antipsychotic Agents; D016578:Crack Cocaine; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole